G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method

被引:54
作者
Choi, SH [1 ]
Park, TG [1 ]
机构
[1] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea
关键词
rhG-CSF; biodegradable; PLGA; nanoparticles; sustained release;
D O I
10.1016/j.ijpharm.2005.12.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A new formulation method was developed for preparing poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles loaded with recombinant human granulocyte colony-stimulating factor (rhG-CSF). Lyophilized rhG-CSF powder and PLGA polymer were directly co-dissolved in a single organic phase, and the resulting solution was dispersed into an aqueous Solution. PLGA nanoparticles encapsulating rhG-CSF were produced by a spontaneous emulsion/solvent diffusion method. In this manner, rhG-CSF was molecularly dissolved in the polymer phase. Release profile of rhG-CSF from PLGA nanoparticles was compared with those from two kinds of PLGA microparticles which were separately prepared by either single oil-in-water (O/W) or double water-in-oil-in-water (W/O/W) emulsion technique. The sizes of rhG-CSF loaded nanoparticles, O/W microparticles, and W/O/W microparticles were about 257 nm, 4.7 mu m, and 4.3 mu m, respectively. For rhG-CSF nanoparticles,about 90% of encapsulated rhG-CSF was released out in a sustained manner from PLGA nanoparticles over a 1 week period, but for rhG-CSF microparticles, only about 20% of rhG-CSF Could be released out during the same period. Reversed phase and size exclusion chromatograms revealed that the structural integrity of released rhG-CSF from nanoparticles was nearly intact, compared to that of native rhG-CSF. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 29 条
[11]  
Kim HK, 1999, BIOTECHNOL BIOENG, V65, P659, DOI 10.1002/(SICI)1097-0290(19991220)65:6<659::AID-BIT6>3.0.CO
[12]  
2-9
[13]   Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release [J].
Kim, HK ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 2004, 98 (01) :115-125
[14]   Characterization and stability of N-terminally PEGylated rhG-CSF [J].
Kinstler, OB ;
Brems, DN ;
Lauren, SL ;
Paige, AG ;
Hamburger, JB ;
Treuheit, MJ .
PHARMACEUTICAL RESEARCH, 1996, 13 (07) :996-1002
[15]  
Knubovets T, 1999, BIOTECHNOL BIOENG, V63, P242, DOI 10.1002/(SICI)1097-0290(19990420)63:2<242::AID-BIT13>3.0.CO
[16]  
2-N
[17]   NEW METHODS OF DRUG DELIVERY [J].
LANGER, R .
SCIENCE, 1990, 249 (4976) :1527-1533
[18]   Hydrophobic ion pairing: Altering the solubility properties of biomolecules [J].
Meyer, JD ;
Manning, MC .
PHARMACEUTICAL RESEARCH, 1998, 15 (02) :188-193
[19]   Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L-lactide-co-glycolide): Protein stability and the effects of stabilizing excipients [J].
Morlock, M ;
Koll, H ;
Winter, G ;
Kissel, T .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (01) :29-36
[20]  
MURTY SB, 2003, AAPS PHARMSCITECH, V4